Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Acute Spinal Cord Injury to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Acute Spinal Cord Injury to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Acute Spinal Cord Injury Therapeutics Clinical Trials 27
Prominent Drugs 29
Latest Clinical Trials News on Acute Spinal Cord Injury 30
Feb 28, 2017: Neuronax Obtains the Authorization to Start its Phase I Clinical Trial in France and Belgium and Strengthens its Patent Portfolio 30
Clinical Trial Profile Snapshots 31
Appendix 57
Abbreviations 57
Definitions 57
Research Methodology 58
Secondary Research 59
About GlobalData 59
Contact Us 59
Disclaimer 60
Source 60

List of Tables
Acute Spinal Cord Injury Therapeutics, Global, Clinical Trials by Region, 2017* 6
Acute Spinal Cord Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Acute Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Acute Spinal Cord Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9
Acute Spinal Cord Injury Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
Acute Spinal Cord Injury Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
Acute Spinal Cord Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 12
Proportion of Acute Spinal Cord Injury to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 13
Acute Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
Acute Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
Proportion of Acute Spinal Cord Injury to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 16
Acute Spinal Cord Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 17
Acute Spinal Cord Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 18
Acute Spinal Cord Injury Therapeutics, Global, Clinical Trials by Phase, 2017* 19
Acute Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 20
Acute Spinal Cord Injury Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
Acute Spinal Cord Injury Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22
Acute Spinal Cord Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
Acute Spinal Cord Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 24
Acute Spinal Cord Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
Acute Spinal Cord Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
Acute Spinal Cord Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

List of Figures
Acute Spinal Cord Injury Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Acute Spinal Cord Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Acute Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Acute Spinal Cord Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 9
Acute Spinal Cord Injury Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
Acute Spinal Cord Injury Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
Acute Spinal Cord Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 12
Proportion of Acute Spinal Cord Injury to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 13
Acute Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
Acute Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
Proportion of Acute Spinal Cord Injury to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 16
Acute Spinal Cord Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 17
Acute Spinal Cord Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 18
Acute Spinal Cord Injury Therapeutics, Global, Clinical Trials by Phase (%), 2017* 19
Acute Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 20
Acute Spinal Cord Injury Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
Acute Spinal Cord Injury Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22
Acute Spinal Cord Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
Acute Spinal Cord Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 24
Acute Spinal Cord Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
Acute Spinal Cord Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
Acute Spinal Cord Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29
GlobalData Methodology 58

Companies Mentioned
BioAxone BioSciences Inc
AOSpine International
Novartis AG
Grupo Ferrer Internacional SA
DP Clinical Inc
Daiichi Sankyo Company Ltd
CJ CheilJedang Corp
Amgen Inc
Allergan Plc
Acorda Therapeutics Inc